Stockreport

Karolinska Development's portfolio company SVF Vaccines presents new preclinical data demonstrating extended effect of SVF-001 in chronic hepatitis B and D [Yahoo! Finance]

Nasdaq, Inc.  (NDAQ) 
Last nasdaq, inc. earnings: 4/22 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.nasdaq.com
PDF STOCKHOLM, Sweden, December 11, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has presented new preclinical [Read more]